These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23684490)

  • 21. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
    Hornberger J; Hirth RA
    Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCFA, Stark eye Medicare ESRD expenditures.
    Koska MT
    Hospitals; 1988 May; 62(10):84. PubMed ID: 3283025
    [No Abstract]   [Full Text] [Related]  

  • 23. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

  • 24. The 2011 ESRD prospective payment system: welcome to the bundle.
    Weiner DE
    Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431
    [No Abstract]   [Full Text] [Related]  

  • 25. Economic impact of case-mix adjusting the dialysis composite rate.
    Hirth RA; Roys EC; Wheeler JR; Messana JM; Turenne MN; Saran R; Pozniak AS; Wolfe RA
    J Am Soc Nephrol; 2005 May; 16(5):1172-6. PubMed ID: 15800122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.
    Nissenson AR; Mayne TJ; Krishnan M
    Am J Kidney Dis; 2011 Apr; 57(4):550-2. PubMed ID: 21333425
    [No Abstract]   [Full Text] [Related]  

  • 27. Trends in prevalence of patient case-mix adjusters used in the Medicare dialysis payment system.
    Hollenbeak CS; Rubin RJ; Tzivelekis S; Stephens JM
    Nephrol News Issues; 2015 Jun; 29(6):24-7, 31-4. PubMed ID: 26237942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 2011 ESRD prospective payment system: an uncontrolled experiment.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2011 Apr; 57(4):542-6. PubMed ID: 21333428
    [No Abstract]   [Full Text] [Related]  

  • 29. Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status.
    Thamer M; Zhang Y; Kaufman J; Kshirsagar O; Cotter D; Hernán MA
    Am J Nephrol; 2014; 40(6):554-60. PubMed ID: 25592645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National health insurance: lessons from the United States experiment.
    Derrick FW; Scott CE
    Health Care Manage Rev; 1995; 20(3):55-63. PubMed ID: 7591752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2011 ESRD prospective payment system and the survival of an endangered species: the perspective of a not-for-profit medium-sized dialysis organization.
    Johnson DS; Meyer KB; Johnson HK
    Am J Kidney Dis; 2011 Apr; 57(4):553-5. PubMed ID: 21333427
    [No Abstract]   [Full Text] [Related]  

  • 32. Streamlining the future: exploring data submission solutions for the small provider.
    Delva O
    Nephrol News Issues; 2011 Apr; 25(4):26-7. PubMed ID: 21542510
    [No Abstract]   [Full Text] [Related]  

  • 33. The due diligence on the ESRD payment cut.
    Neumann ME
    Nephrol News Issues; 2013 Oct; 27(11):8. PubMed ID: 24288801
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2015 Nov; 80(215):68967-9077. PubMed ID: 26552112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of capitation on free-standing dialysis facilities: can you survive?
    McMurray SD; Miller J
    Am J Kidney Dis; 1997 Oct; 30(4):542-8. PubMed ID: 9328370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study.
    Monda KL; Joseph PN; Neumann PJ; Bradbury BD; Rubin RJ
    BMC Nephrol; 2015 May; 16():67. PubMed ID: 25928734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicare pilot program on bundled payments to health care providers could be the next PPS for dialysis.
    Levy R
    Nephrol News Issues; 2012 Feb; 26(2):37-8. PubMed ID: 22439371
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of the bundled end-stage renal disease payment system on patient care.
    Maddux FW
    Blood Purif; 2012; 33(1-3):107-11. PubMed ID: 22269932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicare Enrollment Among Patients With End-Stage Kidney Disease Receiving Dialysis in Outpatient Facilities Between 2005 and 2016.
    Hoffman A; Sloan CE; Maciejewski ML; Wang V
    JAMA; 2020 Apr; 323(13):1314-1316. PubMed ID: 32259222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.